You are here

  • Home
  • Archive
  • Volume 81, Issue Suppl 1
  • POS1573-PARE Patient-Reported Outcome Measures of Pain Alleviation With Cannabinoid Usage in Rheumatoid and Psoriatic Arthritis: a Cross-Sectional Study.

Article info

Article menu

Download PDFPDF

People with Arthritis and Rheumatism in Europe Abstracts
POSTERS only
Innovations in arthritis health care
POS1573-PARE Patient-Reported Outcome Measures of Pain Alleviation With Cannabinoid Usage in Rheumatoid and Psoriatic Arthritis: a Cross-Sectional Study.
Free

Authors

Citation

Jehu T, Bhaskar N, Beg S, et al
POS1573-PARE Patient-Reported Outcome Measures of Pain Alleviation With Cannabinoid Usage in Rheumatoid and Psoriatic Arthritis: a Cross-Sectional Study.
Annals of the Rheumatic Diseases 2022;81:1132-1133.

Publication history

  • First published May 23, 2022.
Online issue publication 
June 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.